Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

Clinical trial NCT07680439 · RECRUITING

Trial details

NCT number: NCT07680439
Sponsor: BrainChild Bio, Inc
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Intrinsic Pontine Glioma DIPG Brain Tumor CNS Tumor Central Nervous System Tumor Pediatric Cancer Adult Cancer Patients CNS Tumor, Childhood CNS Tumor, Adult Brainstem Glioma Diffuse Midline Glioma DMG

Start date: 2026-08-01
Primary completion: 2028-10-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.